45 results
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
, Manufacturing and Supply Chain Chief Medical Officer Francis Michael Conway Noreen Scherer John Berman, CPA Vice President Controller VP, Clinical Operations … , Manufacturing and Supply Chain Chief Medical Officer Francis Michael Conway Noreen Scherer John Berman, CPA Vice President Controller VP, Clinical Operations VP
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
8 Dec 20
Regulation FD Disclosure
7:40am
& Non-clinical R&D Noreen Scherer VP, Clinical Operations Michael Celano Chief Financial Officer Keith E. Lynch, Jr. VP, Manufacturing and Supply Chain Francis
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
1 Jul 21
Other Events
6:11am
& Non-clinical R&D VP, Manufacturing and Supply Chain VP, Finance & Operations VP, Clinical Operations Vice President Controller 25
Scientific Advisory … Bettoun, PhD Keith E. Lynch, Jr. John Berman, CPA Noreen Scherer Francis Michael Conway VP, Discovery & Non-clinical R&D VP, Manufacturing and Supply
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
14 Jun 21
Other Events
5:21pm
VP, Discovery & Non-clinical R&D VP, Manufacturing and Supply Chain VP, Finance & Operations VP, Clinical Operations Vice President Controller … Berman, CPA Noreen Scherer Francis Michael Conway VP, Discovery & Non-clinical R&D VP, Manufacturing and Supply Chain VP, Finance & Operations VP
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
-clinical R&D Noreen Scherer VP, Clinical Operations Michael Celano Chief Financial Officer Keith E. Lynch, Jr. VP, Manufacturing and Supply Chain Francis
8-K
EX-99.2
rtv2we7 j3m9nf7p
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.2
8q407ie6g8h7e2 87
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
eqjq12g
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
3mzqk6 55
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.2
obsp3x
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.1
p6l8tl1w
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
q7ul3msg5cbdii9k9mw
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
hlq0bym85j
18 May 21
Other Events
3:09pm
8-K
EX-99.2
7nnmrjtconnpmc82h36k
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
10-K
lwhtfad
25 Mar 15
Annual report
12:00am